Literature DB >> 14722626

Long-term changes in bone metabolism, bone mineral density, quantitative ultrasound parameters, and fracture incidence after spinal cord injury: a cross-sectional observational study in 100 paraplegic men.

Yvonne Zehnder1, Markus Lüthi, Dieter Michel, Hans Knecht, Romain Perrelet, Isolde Neto, Marius Kraenzlin, Guido Zäch, Kurt Lippuner.   

Abstract

To study the time course of demineralization and fracture incidence after spinal cord injury (SCI), 100 paraplegic men with complete motor loss were investigated in a cross-sectional study 3 months to 30 years after their traumatic SCI. Fracture history was assessed and verified using patients' files and X-rays. BMD of the lumbar spine (LS), femoral neck (FN), distal forearm (ultradistal part = UDR, 1/3 distal part = 1/3R), distal tibial diaphysis (TDIA), and distal tibial epiphysis (TEPI) was measured using DXA. Stiffness of the calcaneus (QUI.CALC), speed of sound of the tibia (SOS.TIB), and amplitude-dependent SOS across the proximal phalanges (adSOS.PHAL) were measured using QUS. Z-Scores of BMD and quantitative ultrasound (QUS) were plotted against time-since-injury and compared among four groups of paraplegics stratified according to time-since-injury (<1 year, stratum I; 1-9 years, stratum II; 10-19 years, stratum III; 20-29 years, stratum IV). Biochemical markers of bone turnover (deoxypyridinoline/creatinine (D-pyr/Cr), osteocalcin, alkaline phosphatase) and the main parameters of calcium phosphate metabolism were measured. Fifteen out of 98 paraplegics had sustained a total of 39 fragility fractures within 1,010 years of observation. All recorded fractures were fractures of the lower limbs, mean time to first fracture being 8.9 +/- 1.4 years. Fracture incidence increased with time-after-SCI, from 1% in the first 12 months to 4.6%/year in paraplegics since >20 years ( p<.01). The overall fracture incidence was 2.2%/year. Compared with nonfractured paraplegics, those with a fracture history had been injured for a longer time ( p<.01). Furthermore, they had lower Z-scores at FN, TEPI, and TDIA ( p<.01 to <.0001), the largest difference being observed at TDIA, compared with the nonfractured. At the lower limbs, BMD decreased with time at all sites ( r=.49 to.78, all p<.0001). At FN and TEPI, bone loss followed a log curve which leveled off between 1 to 3 years after injury. In contrast, Z-scores of TDIA continuously decreased even beyond 10 years after injury. LS BMD Z-score increased with time-since-SCI ( p<.05). Similarly to DXA, QUS allowed differentiation of early and rapid trabecular bone loss (QUI.CALC) vs slow and continuous cortical bone loss (SOS.TIB). Biochemical markers reflected a disproportion between highly elevated bone resorption and almost normal bone formation early after injury. Turnover declined following a log curve with time-after-SCI, however, D-pyr/Cr remained elevated in 30% of paraplegics injured >10 years. In paraplegic men early (trabecular) and persistent (cortical) bone loss occurs at the lower limbs and leads to an increasing fracture incidence with time-after-SCI.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14722626     DOI: 10.1007/s00198-003-1529-6

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  27 in total

1.  Extremity fractures of patients with spinal cord injuries.

Authors:  A E COMARR; R H HUTCHINSON; E BORS
Journal:  Am J Surg       Date:  1962-06       Impact factor: 2.565

2.  Longitudinal study of calcium and bone metabolism in paraplegic patients.

Authors:  P Bergmann; A Heilporn; A Schoutens; J Paternot; A Tricot
Journal:  Paraplegia       Date:  1977-08

3.  Longitudinal study of bone turnover after acute spinal cord injury.

Authors:  D Roberts; W Lee; R C Cuneo; J Wittmann; G Ward; R Flatman; B McWhinney; P E Hickman
Journal:  J Clin Endocrinol Metab       Date:  1998-02       Impact factor: 5.958

4.  Longitudinal study of bone mineral content in the lumbar spine, the forearm and the lower extremities after spinal cord injury.

Authors:  F Biering-Sørensen; H H Bohr; O P Schaadt
Journal:  Eur J Clin Invest       Date:  1990-06       Impact factor: 4.686

5.  Reference curve and diagnostic sensitivity for a new ultrasound device for the phalanges [correction of phalanages], the DBMsonic 1200, in Belgian women.

Authors:  J Joly; R Westhovens; H Borghs; H Peeters; J Tirry; J Nijs; J Dequeker
Journal:  Osteoporos Int       Date:  1999       Impact factor: 4.507

6.  Increased osteoclast-like cells formation in long-term bone marrow cultures from patients with a spinal cord injury.

Authors:  A Demulder; M Guns; A Ismail; E Wilmet; P Fondu; P Bergmann
Journal:  Calcif Tissue Int       Date:  1998-11       Impact factor: 4.333

7.  Fracture rates and risk factors for fractures in patients with spinal cord injury.

Authors:  P Vestergaard; K Krogh; L Rejnmark; L Mosekilde
Journal:  Spinal Cord       Date:  1998-11       Impact factor: 2.772

8.  Quantitative ultrasound of the tibia: a novel approach for assessment of bone status.

Authors:  A J Foldes; A Rimon; D D Keinan; M M Popovtzer
Journal:  Bone       Date:  1995-10       Impact factor: 4.398

9.  Human synthetic calcitonin gene-related peptide inhibits bone resorption in vitro.

Authors:  S M D'Souza; I MacIntyre; S I Girgis; G R Mundy
Journal:  Endocrinology       Date:  1986-07       Impact factor: 4.736

10.  Bone mineral content of the lumbar spine and lower extremities years after spinal cord lesion.

Authors:  F Biering-Sørensen; H Bohr; O Schaadt
Journal:  Paraplegia       Date:  1988-10
View more
  94 in total

1.  Zoledronic acid administration failed to prevent bone loss at the knee in persons with acute spinal cord injury: an observational cohort study.

Authors:  William A Bauman; Christopher M Cirnigliaro; Michael F La Fountaine; LeighAnn Martinez; Steven C Kirshblum; Ann M Spungen
Journal:  J Bone Miner Metab       Date:  2014-08-27       Impact factor: 2.626

Review 2.  Bone Imaging and Fracture Risk after Spinal Cord Injury.

Authors:  W Brent Edwards; Thomas J Schnitzer
Journal:  Curr Osteoporos Rep       Date:  2015-10       Impact factor: 5.096

3.  Reduced loading due to spinal-cord injury at birth results in "slender" bones: a case study.

Authors:  L M Giangregorio; N McCartney
Journal:  Osteoporos Int       Date:  2006-09-14       Impact factor: 4.507

4.  Effect of a convenient single 90-mg pamidronate dose on biochemical markers of bone metabolism in patients with acute spinal cord injury.

Authors:  Jeffrey I Mechanick; Kan Liu; David M Nierman; Adam Stein
Journal:  J Spinal Cord Med       Date:  2006       Impact factor: 1.985

5.  Effect of sports activity on bone mineral density in wheelchair athletes.

Authors:  Kimiko Miyahara; Da-Hong Wang; Keiko Mori; Kayo Takahashi; Nobuyuki Miyatake; Bing-Ling Wang; Tomoko Takigawa; Jiro Takaki; Keiki Ogino
Journal:  J Bone Miner Metab       Date:  2008-01-10       Impact factor: 2.626

6.  Physiatrists' opinions and practice patterns for bone health after SCI.

Authors:  M C Ashe; J J Eng; A Krassioukov
Journal:  Spinal Cord       Date:  2008-08-19       Impact factor: 2.772

7.  Risk factors for the development of osteoporosis after spinal cord injury. A 12-month follow-up study.

Authors:  L Gifre; J Vidal; J L Carrasco; A Muxi; E Portell; A Monegal; N Guañabens; P Peris
Journal:  Osteoporos Int       Date:  2015-05-05       Impact factor: 4.507

Review 8.  Bone loss and muscle atrophy in spinal cord injury: epidemiology, fracture prediction, and rehabilitation strategies.

Authors:  Lora Giangregorio; Neil McCartney
Journal:  J Spinal Cord Med       Date:  2006       Impact factor: 1.985

9.  Acute suppression of bone turnover with calcium infusion in persons with spinal cord injury.

Authors:  William A Bauman; Run-Lin Zhang; Nancy Morrison; Ann M Spungen
Journal:  J Spinal Cord Med       Date:  2009       Impact factor: 1.985

10.  FRAX assessment of osteoporotic fracture probability in Switzerland.

Authors:  K Lippuner; H Johansson; J A Kanis; R Rizzoli
Journal:  Osteoporos Int       Date:  2009-06-11       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.